ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.380,70
1,08%
S&P 500
5.614,66
-1,07%
Dow Jones
41.581,31
-0,62%
Euro vs US Dollar
1,09449
0,24%
Bitcoin
82.061,48
-2,38%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) News

GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GENE
DatumZeitQuelleÜberschriftSymbolFirma
12/12/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
02/12/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
20/11/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
23/09/202414h30GlobeNewswire Inc.Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2NASDAQ:GENEGenetic Technologies Ltd
11/09/202415h47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
11/09/202414h15GlobeNewswire Inc.Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 ClinicsNASDAQ:GENEGenetic Technologies Ltd
28/08/202414h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
15/08/202414h00GlobeNewswire Inc.Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platformNASDAQ:GENEGenetic Technologies Ltd
09/08/202414h00GlobeNewswire Inc.Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15NASDAQ:GENEGenetic Technologies Ltd
31/07/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
26/07/202414h00GlobeNewswire Inc.Genetic Technologies Strategic Restructure Driving USA Sales GrowthNASDAQ:GENEGenetic Technologies Ltd
16/07/202414h00GlobeNewswire Inc.Genetic Technologies Announces Appointment of Chief Financial Officer & Company SecretaryNASDAQ:GENEGenetic Technologies Ltd
09/07/202414h00GlobeNewswire Inc.GeneType to Enter Canadian and New Zealand MarketsNASDAQ:GENEGenetic Technologies Ltd
25/06/202414h00GlobeNewswire Inc.GeneType Identifies 79.5% of People Tested are at Risk of Serious DiseaseNASDAQ:GENEGenetic Technologies Ltd
21/06/202414h00GlobeNewswire Inc.Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27NASDAQ:GENEGenetic Technologies Ltd
18/06/202414h00GlobeNewswire Inc.Genetic Technologies Expands Operational Capacity in North AmericaNASDAQ:GENEGenetic Technologies Ltd
05/06/202414h00GlobeNewswire Inc.GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk TestNASDAQ:GENEGenetic Technologies Ltd
05/06/202412h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
29/05/202414h00GlobeNewswire Inc.GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian CancerNASDAQ:GENEGenetic Technologies Ltd
29/05/202412h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
28/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
23/05/202414h00GlobeNewswire Inc.GeneType and Humanise Health host “Know Your Risk” EventNASDAQ:GENEGenetic Technologies Ltd
06/05/202414h00GlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
22/04/202421h00GlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
18/04/202418h17GlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
17/04/202414h00GlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
16/04/202414h00GlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
11/04/202414h00GlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
08/04/202414h00GlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
02/04/202414h05GlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
 Showing the most relevant articles for your search:NASDAQ:GENE

Kürzlich von Ihnen besucht

DOWI
B15BDRD
DJ BRIC Brazil 15 DR
LSE
58SL
Sg Issuer 27
LSE
43PZ
Investec Bnk 24
ASX
FIIN
FIL Responsible Entity A...
UNSW
LEADETH
Lead Token
EU
DPT
ST Dupont
BIT
QFID
B Antonveneta
LSE
KQ73
Morg.st.b.v 25
LSE
PV14
Ksa Sukuk.30 U
COIN
BGTTETH
Baguette Token
LSE
RA36
Mar Fin 24
BIT
CLEU
Lyxor Msci Europe Esg Cl...
COIN
BGTTUSD
Baguette Token
LSE
QL07
Morg.st.b.v 25
LSE
11IN
Investec Bnk 23
COIN
TUDAUSD
TudaToken
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten